Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-08

Clinical Trial Update: Prucalopride Versus Placebo in Gastroparesis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating prucalopride versus placebo for gastroparesis; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRUCALOPRIDE (Prucalopride)

Snippet

Sponsor: University of Calgary | Conditions: Gastroparesis, Diabetes Mellitus | Phase 2, Phase 3 | Status: COMPLETED